UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices, including zip code)
(
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Nasdaq Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 | Results of Operations and Financial Condition. |
On May 6, 2021, Laureate Education, Inc. (the “Company”) issued an earnings release announcing its financial results for the quarter ended March 31, 2021. A copy of the earnings release is furnished herewith as Exhibit 99.1 and incorporated in this Item 2.02 by reference.
Item 7.01 | Regulation FD Disclosure. |
On May 6, 2021, the Company made available on the investor relations section of its website its first quarter of 2021 Earnings Presentation (the “Presentation”). A copy of the Presentation is furnished herewith as Exhibit 99.2 and incorporated in this Item 7.01 by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | Description | |
99.1 | Earnings Release issued by Laureate Education, Inc. on May 6, 2021. | |
99.2 | First Quarter of 2021 Earnings Presentation. | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
The information contained in Item 2.02, including Exhibit 99.1 hereto, and Item 7.01, including Exhibit 99.2 hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Such information in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in any such filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LAUREATE EDUCATION, INC. | ||
By: | /s/ RICHARD M. BUSKIRK | |
Name: | Richard M. Buskirk | |
Title: | Senior Vice President and Chief Financial Officer |
Date: May 6, 2021
3
Exhibit 99.1
LAUREATE EDUCATION REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2021
Strong New Enrollment Trends in Peru During Primary Intake Cycle
Company Announces Increase in Share Repurchase Authorization
BALTIMORE, MARYLAND - May 6, 2021 - Laureate Education, Inc. (NASDAQ: LAUR) today announced financial results for the first quarter of 2021.
Unless indicated otherwise, the results presented below relate to Continuing Operations, which encompass Laureate's operations in Mexico and Peru, as well as Laureate's Corporate overhead expenses.
First Quarter 2021 Highlights (compared to first quarter 2020):
· | New enrollments increased 59%, up 5% adjusted for the timing of semester start dates in Peru during the prior year (due to the COVID-19 pandemic). |
· | Total enrollments increased 2%. |
· | On a reported basis, revenue increased 1% to $194.7 million. On an organic constant currency basis1, revenue increased 5%, and was favorably affected by the timing of semester start dates in Peru. |
· | Operating loss for the first quarter of 2021 was $(86.4) million, primarily driven by impairment charges of $56.7 million, largely attributable to the Laureate tradename, as compared to operating loss of $(77.1) million for the first quarter of 2020. |
· | Net loss (including Discontinued Operations) for the first quarter of 2021 was $(164.9) million, as compared to net income (including Discontinued Operations) of $98.3 million for the first quarter of 2020, which benefited from a discrete tax benefit. |
· | Adjusted EBITDA for the first quarter (seasonally low quarter) of 2021 was $9.7 million, as compared to Adjusted EBITDA of $(29.4) million for the first quarter of 2020. Adjusted EBITDA in the first quarter of 2021 was favorably affected by the timing of semester start dates in Peru. |
Eilif Serck-Hanssen, President and Chief Executive Officer, said, “The robust performance during our primary intake in Peru, despite continued challenges from the pandemic, highlights the strong value proposition to our students and the quality of our offerings. We are encouraged by the momentum in the business under our new model as a regional operator in Mexico and Peru. At the same time, we are pleased to announce a $200 million upsizing of our share buyback authorization to $500 million.”
First Quarter 2021 Results
New enrollments for the first quarter of 2021 increased 59%, compared to new enrollment activity for the first quarter of 2020, and total enrollments were up 2% compared to the prior year period. Adjusted for the timing of semester start dates in Peru during the prior year (due to the COVID-19 pandemic), new enrollments increased 5%. The first quarter represents the primary intake cycle for Peru, and results for the first quarter of 2021 were robust, with new and total enrollments increasing 11% and 10%, respectively, as compared to prior year period on a timing-adjusted basis. Mexico’s primary intake will occur in September. For Mexico’s smaller intake in the first quarter, new enrollments were down 4% compared to the prior year period, and total enrollment was down 5%, reflecting the impact from its primary intake cycle during the third quarter of 2020 which was impacted by the pandemic.
1 Organic constant currency results exclude the period-over-period impact from currency fluctuations, acquisitions and divestitures, and other items.
1
For the first quarter of 2021, revenue on a reported basis was $194.7 million, an increase of $2.4 million, or 1%, when compared to the first quarter of 2020. On an organic constant currency basis, revenue increased 5% and was favorably affected by the timing of semester start dates in Peru. The operating loss for the first quarter of 2021 was $(86.4) million, primarily driven by impairment charges of $56.7 million, largely attributable to the Laureate tradename, as compared to an operating loss of $(77.1) million for the first quarter of 2020. Net loss (including Discontinued Operations) for the first quarter of 2021 was $(164.9) million, as compared to net income (including Discontinued Operations) of $98.3 million for the first quarter of 2020, which benefited from a discrete tax benefit. Basic and diluted loss per share for the first quarter of 2021 were $(0.82).
Adjusted EBITDA for the first quarter (seasonally low quarter) of 2021 was $9.7 million, as compared to Adjusted EBITDA of $(29.4) million for the first quarter of 2020. Adjusted EBITDA in the first quarter of 2021 was favorably affected by the timing of semester start dates in Peru.
Balance Sheet and Capital Structure
Laureate has a strong financial position with significant liquidity. As of March 31, 2021, Laureate had $833 million of cash (of which $272 million was recorded at subsidiaries that were classified as held for sale), and gross debt, including seller notes, of $1.1 billion (of which $118 million was recorded at subsidiaries that were classified as held for sale). Accordingly, total debt, net of cash, was $286 million as of March 31, 2021.
The cash and debt balances as of March 31, 2021 are prior to approximately $1.95 billion of net proceeds (net of taxes, fees and other expenses) that are anticipated from the sale of Walden University and Laureate's operations in Brazil, for which definitive agreements have been executed.
On May 4, 2021, the Company repaid $500 million of its outstanding 8.25% Senior Notes. The Company anticipates repaying the remaining $298.7 million balance following the closing of the sale of Laureate's operations in Brazil, at which times the Senior Notes will be fully repaid.
Increase to Share Repurchase Program
Laureate’s board of directors has approved an increase in the Company’s existing share repurchase program, from $300 million to $500 million, to acquire shares of the Company’s Class A common stock. The Company expects to finance the additional $200 million of repurchases with proceeds received from the sale of the Company’s Brazil operations, from cash on-hand or from its revolving credit facility, or a combination thereof. As of April 30, 2021, the Company has repurchased approximately $246 million of shares under the authorization. The Company expects to complete the repurchase program by no later than the end of 2021, dependent on market conditions.
2
Outlook for Fiscal 2021 and 2022
Laureate is re-affirming its previously issued full-year 2021 guidance and outlook for 2022.
Based on the current foreign exchange spot rates2, Laureate currently expects its full-year 2021 results to be as follows:
Continuing Operations 2021
· | Total enrollments expected to be approximately 337,000, essentially flat versus 2020; |
· | Revenues expected to be in the range of $1,000 to $1,040 million, reflecting a decline of 2% to growth of 2% on an organic constant currency basis versus 2020; and |
· | Adjusted EBITDA expected to be in the range of $180 to $190 million, reflecting a decline in growth of 8%-13% on an organic constant currency basis versus 2020. Anticipated Adjusted EBITDA in 2021 is prior to rightsizing of Corporate G&A infrastructure and includes approximately $13 million of non-cash charges related to the write-off of an indemnification asset related to a prior period acquisition. |
Outlook for Fiscal 2022
Laureate anticipates that by the end of 2021, the Corporate G&A restructuring will be largely completed (following completion of the pending asset sales), the impact of the COVID-19 pandemic will mostly be abated and that the Company will return to growth levels more in-line with historical performance prior to the COVID-19 pandemic.
Based on the current foreign exchange spot rates2, and the above assumptions, Laureate currently expects its full-year 2022 results to be as follows:
Continuing Operations 2022
· | Total enrollments expected to be approximately 350,000, reflecting growth of 4% versus 2021 expectations; |
· | Revenues expected to be approximately $1,080 million, reflecting growth of 6% on an organic constant currency basis versus 2021 expectations; and |
· | Adjusted EBITDA expected to be approximately $280 million, reflecting growth of approximately 51% on an organic constant currency basis versus 2021 expectations, benefiting from the reduction in G&A and anticipated operational improvements. |
The above outlook assumes that all entities currently included within Continuing Operations remain there for the entirety of 2021 and 2022. If and when additional entities are required to be moved to Discontinued Operations, our outlook will be subject to revision.
Reconciliations of forward-looking non-GAAP measures (2021 Adjusted EBITDA outlook and 2022 Adjusted EBITDA outlook) to the relevant forward-looking GAAP measures are not being provided, as Laureate does not currently have sufficient data to accurately estimate the variables and individual adjustments for such outlooks and reconciliations. Due to this uncertainty, the Company cannot reconcile projected Adjusted EBITDA to projected net income without unreasonable effort.
Please see the “Forward-Looking Statements” section in this release for a discussion of certain risks related to this outlook.
3
2 Based on actual FX rates for January-April 2021, and current spot FX rates (local currency per U.S. Dollar) of MXN 19.97 and PEN 3.81 for May 2021 - December 2022. FX impact may change based on fluctuations in currency rates in future periods.
Conference Call
Laureate will host an earnings conference call today at 8:30 am ET. Interested parties are invited to listen to the earnings call by dialing 1-855-307-2849 (for U.S.- based callers) or 1-703-639-1262 (for international callers), and requesting to join the Laureate conference call, conference ID 3352076. Replays of the entire call will be available through May 13, 2021, at 1-855-859-2056 (for U.S.- based callers) and at 1-404-537-3406 (for international callers), conference ID 3352076. The webcast of the conference call, including replays, and a copy of this press release and the related slides will be made available through the Investor Relations section of Laureate’s website at www.laureate.net.
Forward-Looking Statements
This press release includes statements that express Laureate’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, ‘‘forward-looking statements’’ within the meaning of the federal securities laws, which involve risks and uncertainties. Laureate’s actual results may vary significantly from the results anticipated in these forward-looking statements. You can identify forward-looking statements because they contain words such as ‘‘believes,’’ ‘‘expects,’’ ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘seeks,’’ ‘‘approximately,’’ ‘‘intends,’’ ‘‘plans,’’ ‘‘estimates’’ or ‘‘anticipates’’ or similar expressions that concern our strategy, plans or intentions. All statements we make relating to (i) guidance (including, but not limited to, total enrollments, revenues, and Adjusted EBITDA), (ii) our planned divestitures, the expected proceeds generated therefrom and the expected reduction in revenue resulting therefrom, (iii) our exploration of strategic alternatives and potential future plans, strategies or transactions that may be identified, explored or implemented as a result of such review process and any resulting litigation or dispute therewith, (iv) anticipated share repurchases and (v) the potential impact of the COVID-19 pandemic on our business or the global economy as a whole are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. All of these forward-looking statements are subject to risks and uncertainties that may change at any time, including, with respect to our exploration of strategic alternatives, risks and uncertainties as to the terms, timing, structure, benefits and costs of any divestiture or separation transaction and whether one will be consummated at all, and the impact of any divestiture or separation transaction on our remaining businesses. Accordingly, our actual results may differ materially from those we expected. We derive most of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations are disclosed in our Annual Report on Form 10-K filed with the SEC on February 25, 2021. These forward-looking statements speak only as of the time of this release and we do not undertake to publicly update or revise them, whether as a result of new information, future events or otherwise, except as required by law.
4
Presentation of Non-GAAP Measures
In addition to the results provided in accordance with U.S. generally accepted accounting principles (GAAP) throughout this press release, Laureate provides the non-GAAP measurements of Adjusted EBITDA and total debt, net of cash (or net debt). We have included these non-GAAP measurements because they are key measures used by our management and board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short- and long-term operational plans.
Adjusted EBITDA consists of income (loss) from continuing operations, adjusted for the items included in the accompanying reconciliation. The exclusion of certain expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core business. Additionally, Adjusted EBITDA is a key input into the formula used by the compensation committee of our board of directors and our Chief Executive Officer in connection with the payment of incentive compensation to our executive officers and other members of our management team. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.
Total debt, net of cash (or net debt) consists of total gross debt, including seller notes, for Continuing Operations and Discontinued Operations, less total cash and cash equivalents for Continuing Operations and Discontinued Operations. Net debt provides a useful indicator about Laureate’s leverage and liquidity.
Laureate’s calculations of Adjusted EBITDA and total debt, net of cash (or net debt) are not necessarily comparable to calculations performed by other companies and reported as similarly titled measures. These non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP results. Adjusted EBITDA is reconciled from the GAAP measure in the attached table “Non-GAAP Reconciliation.”
We evaluate our results of operations on both an as reported and an organic constant currency basis. The organic constant currency presentation, which is a non-GAAP measure, excludes the impact of fluctuations in foreign currency exchange rates, acquisitions and divestitures, and other items. We believe that providing organic constant currency information provides valuable supplemental information regarding our results of operations, consistent with how we evaluate our performance. We calculate organic constant currency amounts using the change from prior-period average foreign exchange rates to current-period average foreign exchange rates, as applied to local-currency operating results for the current period, and then exclude the impact of acquisitions and divestitures and other items described in the accompanying presentation.
About Laureate Education, Inc.
At Laureate Education, Inc., we understand the transformative power of education. For more than 22 years, we have remained committed to making a positive impact in the communities we serve by providing accessible, high-quality undergraduate, graduate and specialized degree programs. We know that when our students succeed, countries prosper and societies benefit. Our longstanding commitment to operating with purpose is evidenced by becoming the first Public Benefit Corporation publicly listed on any stock exchange in the world.
5
Key Metrics and Financial Tables
(Dollars in millions, except per share amounts, and may not sum due to rounding)
New and Total Enrollments by segment
New Enrollments | Total Enrollments | |||||||||||||||||||||||||||||||||||||||
Change | Change | |||||||||||||||||||||||||||||||||||||||
YTD
1Q 2021 | YTD
1Q 2020 | Total | Organic | Timing
Adj. (2) | As of 03/31/2021 | As of 03/31/2020 | Total | Organic | Timing Adj. (2) | |||||||||||||||||||||||||||||||
Mexico | 27,300 | 28,400 | (4 | )% | (4 | )% | (4 | )% | 183,700 | 193,800 | (5 | )% | (5 | )% | (5 | )% | ||||||||||||||||||||||||
Peru | 47,100 | 18,300 | 157 | % | 157 | % | 11 | % | 182,300 | 163,500 | 11 | % | 11 | % | 10 | % | ||||||||||||||||||||||||
Laureate (1) | 74,400 | 46,700 | 59 | % | 59 | % | 5 | % | 366,000 | 357,300 | 2 | % | 2 | % | 2 | % |
(1) Excludes new and total enrollments for our discontinued operations
(2) Q1 2020 enrollment shown pro-forma to include UPN-Peru semester start; due to COVID-19, the semester start date pushed was to April 6th in 2020
6
Consolidated Statements of Operations
For the three months ended March 31, | ||||||||||||
IN MILLIONS | 2021 | 2020 | Change | |||||||||
Revenues | $ | 194.7 | $ | 192.3 | $ | 2.4 | ||||||
Costs and expenses: | ||||||||||||
Direct costs | 181.8 | 220.6 | (38.8 | ) | ||||||||
General and administrative expenses | 42.6 | 45.1 | (2.5 | ) | ||||||||
Loss on impairment of assets | 56.7 | 3.8 | 52.9 | |||||||||
Operating loss | (86.4 | ) | (77.1 | ) | (9.3 | ) | ||||||
Interest income | 0.7 | 0.6 | 0.1 | |||||||||
Interest expense | (23.5 | ) | (25.3 | ) | 1.8 | |||||||
Gain on derivatives | 29.3 | 0.8 | 28.5 | |||||||||
Other expense, net | — | (0.1 | ) | 0.1 | ||||||||
Foreign currency exchange gain, net | 28.2 | 78.7 | (50.5 | ) | ||||||||
Loss on disposal of subsidiaries, net | — | (1.8 | ) | 1.8 | ||||||||
Loss from continuing operations before income taxes and equity in net income of affiliates | (51.7 | ) | (24.1 | ) | (27.6 | ) | ||||||
Income tax (expense) benefit | (112.9 | ) | 230.0 | (342.9 | ) | |||||||
Equity in net income of affiliates, net of tax | — | 0.2 | (0.2 | ) | ||||||||
(Loss) income from continuing operations | (164.5 | ) | 206.1 | (370.6 | ) | |||||||
Loss from discontinued operations, net of tax | (0.4 | ) | (107.8 | ) | 107.4 | |||||||
Net (loss) income | (164.9 | ) | 98.3 | (263.2 | ) | |||||||
Net loss attributable to noncontrolling interests | — | 1.3 | (1.3 | ) | ||||||||
Net (loss) income attributable to Laureate Education, Inc. | $ | (164.9 | ) | $ | 99.6 | $ | (264.5 | ) | ||||
Net (loss) income available to common stockholders | $ | (164.9 | ) | $ | 99.6 | $ | (264.5 | ) | ||||
Basic and diluted earnings (loss) per share: | ||||||||||||
Basic weighted average shares outstanding | 200.2 | 209.8 | (9.6 | ) | ||||||||
Diluted weighted average shares outstanding | 200.2 | 210.2 | (10.0 | ) | ||||||||
Basic and diluted (loss) earnings per share | $ | (0.82 | ) | $ | 0.47 | $ | (1.29 | ) |
7
Revenue and Adjusted EBITDA by segment (continuing operations)
IN MILLIONS
% Change | $ Variance Components | |||||||||||||||||||||||||||||||||||
For the three months ended March 31, | 2021 | 2020 | Reported | Organic Currency(3) | Total | Organic
Constant Currency | Other | Acq/Div. | FX | |||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||||||||||
Mexico | $ | 135.4 | $ | 154.2 | (12 | )% | (11 | )% | $ | (18.8 | ) | $ | (16.2 | ) | $ | — | $ | — | $ | (2.6 | ) | |||||||||||||||
Peru | 57.5 | 36.5 | 58 | % | 68 | % | 21.0 | 25.0 | — | — | (4.0 | ) | ||||||||||||||||||||||||
Corporate & Eliminations | 1.8 | 1.6 | 13 | % | 13 | % | 0.2 | 0.2 | — | — | — | |||||||||||||||||||||||||
Total Revenues | $ | 194.7 | $ | 192.3 | 1 | % | 5 | % | $ | 2.4 | $ | 9.0 | $ | — | $ | — | $ | (6.6 | ) | |||||||||||||||||
Adjusted EBITDA | ||||||||||||||||||||||||||||||||||||
Mexico | $ | 17.3 | $ | 23.3 | (26 | )% | (1 | )% | $ | (6.0 | ) | $ | (0.3 | ) | $ | (6.8 | ) | $ | — | $ | 1.1 | |||||||||||||||
Peru | 11.6 | (26.7 | ) | 143 | % | 146 | % | 38.3 | 39.0 | — | — | (0.7 | ) | |||||||||||||||||||||||
Corporate & Eliminations | (19.2 | ) | (26.0 | ) | 26 | % | 26 | % | 6.8 | 6.8 | — | — | — | |||||||||||||||||||||||
Total Adjusted EBITDA | $ | 9.7 | $ | (29.4 | ) | 133 | % | 155 | % | $ | 39.1 | $ | 45.5 | $ | (6.8 | ) | $ | — | $ | 0.4 | ||||||||||||||||
(3) | Organic Constant Currency results exclude the period-over-period impact from currency fluctuations, acquisitions and divestitures, and other items. Other items include the impact of acquisition-related contingent liabilities for taxes other-than-income tax, net of changes in recorded indemnification assets. Organic Constant Currency is calculated using the change from prior-period average foreign exchange rates to current-period average foreign exchange rates, as applied to local-currency operating results for the current period. The “Organic Constant Currency” % changes are calculated by dividing the Organic Constant Currency amounts by the 2020 Revenues and Adjusted EBITDA amounts, excluding the impact of the divestitures. |
8
Consolidated Balance Sheets
IN MILLIONS | March 31, 2021 | December 31, 2020 | Change | |||||||||
Assets | ||||||||||||
Cash and cash equivalents | $ | 561.3 | $ | 750.1 | $ | (188.8 | ) | |||||
Receivables (current), net | 115.1 | 111.9 | 3.2 | |||||||||
Other current assets | 167.0 | 146.8 | 20.2 | |||||||||
Current assets held for sale | 467.8 | 435.0 | 32.8 | |||||||||
Property and equipment, net | 543.0 | 578.5 | (35.5 | ) | ||||||||
Operating lease right-of-use assets, net | 428.2 | 462.8 | (34.6 | ) | ||||||||
Goodwill and other intangible assets | 715.8 | 800.4 | (84.6 | ) | ||||||||
Deferred income taxes | 90.6 | 130.6 | (40.0 | ) | ||||||||
Other long-term assets | 56.9 | 72.4 | (15.5 | ) | ||||||||
Long-term assets held for sale | 1,338.3 | 1,482.5 | (144.2 | ) | ||||||||
Total assets | $ | 4,484.0 | $ | 4,970.9 | $ | (486.9 | ) | |||||
Liabilities and stockholders' equity | ||||||||||||
Accounts payable and accrued expenses | $ | 178.7 | $ | 200.9 | $ | (22.2 | ) | |||||
Deferred revenue and student deposits | 85.9 | 47.2 | 38.7 | |||||||||
Total operating leases, including current portion | 476.0 | 519.1 | (43.1 | ) | ||||||||
Total long-term debt, including current portion | 951.0 | 995.7 | (44.7 | ) | ||||||||
Other liabilities | 283.5 | 240.0 | 43.5 | |||||||||
Current and long-term liabilities held for sale | 613.7 | 702.3 | (88.6 | ) | ||||||||
Total liabilities | 2,588.8 | 2,705.2 | (116.4 | ) | ||||||||
Redeemable noncontrolling interests and equity | 1.7 | 1.7 | — | |||||||||
Total stockholders' equity | 1,893.5 | 2,263.9 | (370.4 | ) | ||||||||
Total liabilities and stockholders' equity | $ | 4,484.0 | $ | 4,970.9 | $ | (486.9 | ) |
9
Consolidated Statements of Cash Flows
For the three months ended March 31, | ||||||||||||
IN MILLIONS | 2021 | 2020 | Change | |||||||||
Cash flows from operating activities | ||||||||||||
Net (loss) income | $ | (164.9 | ) | $ | 98.3 | $ | (263.2 | ) | ||||
Depreciation and amortization | 22.7 | 44.2 | (21.5 | ) | ||||||||
Loss on impairment of assets | 57.7 | 3.8 | 53.9 | |||||||||
Loss on sales and disposal of subsidiaries and property and equipment, net | 16.5 | 21.2 | (4.7 | ) | ||||||||
Gain on derivative instruments | (29.3 | ) | (0.8 | ) | (28.5 | ) | ||||||
Deferred income taxes | 84.4 | (248.7 | ) | 333.1 | ||||||||
Unrealized foreign currency exchange gain | (23.7 | ) | (29.7 | ) | 6.0 | |||||||
Income tax receivable/payable, net | (16.7 | ) | 2.7 | (19.4 | ) | |||||||
Working capital, excluding tax accounts | 25.6 | 41.8 | (16.2 | ) | ||||||||
Other non-cash adjustments | 39.1 | 63.7 | (24.6 | ) | ||||||||
Net cash provided by (used in) operating activities | 11.3 | (3.5 | ) | 14.8 | ||||||||
Cash flows from investing activities | ||||||||||||
Purchase of property and equipment | (11.7 | ) | (24.6 | ) | 12.9 | |||||||
Expenditures for deferred costs | (1.9 | ) | (3.5 | ) | 1.6 | |||||||
Receipts from sales of discontinued operations, net of cash sold, and property and equipment | 30.8 | 4.0 | 26.8 | |||||||||
Payments on derivatives related to sale of discontinued operations | (18.3 | ) | — | (18.3 | ) | |||||||
Investing other, net | — | 0.1 | (0.1 | ) | ||||||||
Net cash used in investing activities | (1.1 | ) | (24.0 | ) | 22.9 | |||||||
Cash flows from financing activities | ||||||||||||
(Decrease) increase in long-term debt, net | (52.7 | ) | 273.0 | (325.7 | ) | |||||||
Payments of deferred purchase price for acquisitions | — | (1.5 | ) | 1.5 | ||||||||
Proceeds from exercise of stock options | — | 26.8 | (26.8 | ) | ||||||||
Payments to repurchase common stock | (145.2 | ) | (29.2 | ) | (116.0 | ) | ||||||
Financing other, net | (1.2 | ) | (1.1 | ) | (0.1 | ) | ||||||
Net cash (used in) provided by financing activities | (199.2 | ) | 267.9 | (467.1 | ) | |||||||
Effects of exchange rate changes on Cash and cash equivalents and Restricted cash | (6.9 | ) | (7.7 | ) | 0.8 | |||||||
Change in cash included in current assets held for sale | (3.5 | ) | 10.1 | (13.6 | ) | |||||||
Net change in Cash and cash equivalents and Restricted cash | (199.3 | ) | 242.8 | (442.1 | ) | |||||||
Cash and cash equivalents and Restricted cash at beginning of period | 867.3 | 97.8 | 769.5 | |||||||||
Cash and cash equivalents and Restricted cash at end of period | $ | 668.0 | $ | 340.6 | $ | 327.4 | ||||||
Liquidity (including Undrawn Revolver) | $ | 971.3 | $ | 300.6 | $ | 670.7 |
10
Non-GAAP Reconciliation
The following table reconciles (Loss) income from continuing operations to Adjusted EBITDA:
For the three months ended March 31, | ||||||||||||
IN MILLIONS | 2021 | 2020 | Change | |||||||||
(Loss) income from continuing operations | $ | (164.5 | ) | $ | 206.1 | $ | (370.6 | ) | ||||
Plus: | ||||||||||||
Equity in net income of affiliates, net of tax | — | (0.2 | ) | 0.2 | ||||||||
Income tax expense (benefit) | 112.9 | (230.0 | ) | 342.9 | ||||||||
Loss from continuing operations before income taxes and equity in net income of affiliates | (51.7 | ) | (24.1 | ) | (27.6 | ) | ||||||
Plus: | ||||||||||||
Loss on disposal of subsidiaries, net | — | 1.8 | (1.8 | ) | ||||||||
Foreign currency exchange gain, net | (28.2 | ) | (78.7 | ) | 50.5 | |||||||
Other expense, net | — | 0.1 | (0.1 | ) | ||||||||
Gain on derivatives | (29.3 | ) | (0.8 | ) | (28.5 | ) | ||||||
Interest expense | 23.5 | 25.3 | (1.8 | ) | ||||||||
Interest income | (0.7 | ) | (0.6 | ) | (0.1 | ) | ||||||
Operating loss | (86.4 | ) | (77.1 | ) | (9.3 | ) | ||||||
Plus: | ||||||||||||
Depreciation and amortization | 22.8 | 19.7 | 3.1 | |||||||||
EBITDA | (63.6 | ) | (57.4 | ) | (6.2 | ) | ||||||
Plus: | ||||||||||||
Share-based compensation expense (4) | 1.3 | 1.5 | (0.2 | ) | ||||||||
Loss on impairment of assets (5) | 56.7 | 3.8 | 52.9 | |||||||||
EiP implementation expenses (6) | 15.3 | 22.8 | (7.5 | ) | ||||||||
Adjusted EBITDA | $ | 9.7 | $ | (29.4 | ) | $ | 39.1 |
(4) Represents non-cash, share-based compensation expense pursuant to the provisions of ASC Topic 718, "Stock Compensation."
(5) Represents non-cash charges related to impairments of long-lived assets.
(6) Excellence-in-Process (EiP) implementation expenses are related to our enterprise-wide initiative to optimize and standardize Laureate’s processes, creating vertical integration of procurement, information technology, finance, accounting and human resources. It included the establishment of regional shared services organizations (SSOs) around the world, as well as improvements to the Company's system of internal controls over financial reporting. The EiP initiative also includes other back- and mid-office areas, as well as certain student-facing activities, expenses associated with streamlining the organizational structure, an enterprise-wide program aimed at revenue growth, and certain non-recurring costs incurred in connection with the planned and completed dispositions.
11
Investor Relations Contact:
ir@laureate.net
Media Contacts:
Laureate Education |
Adam Smith |
adam.smith@laureate.net |
U.S.: +1 (443) 255 0724 |
Source: Laureate Education, Inc. |
12
Exhibit 99.2
1 © 2021 Laureate Education, Inc. May 6, 2021 First Quarter 2021 Earnings Presentation
2 © 2021 Laureate Education, Inc. This presentation includes statements that express Laureate’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, ‘‘forward - looking statements’’ within the meaning of the federal secur ities laws, which involve risks and uncertainties. Laureate’s actual results may vary significantly from the results anticipated in these forward - looking statements . You can identify forward - looking statements because they contain words such as ‘‘believes,’’ ‘‘expects,’’ ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘seeks,’’ ‘‘approxim ate ly,’’ ‘‘intends,’’ ‘‘plans,’’ ‘‘estimates’’ or ‘‘anticipates’’ or similar expressions that concern our strategy, plans or intentions. All statements we make relating to (i) gu idance (including, but not limited to, total enrollments, revenues and Adjusted EBITDA), (ii) our planned divestitures, the expected proceeds generated therefrom and the exp ected reduction in revenue resulting therefrom, (iii) our exploration of strategic alternatives and potential future plans, strategies or transactions t hat may be identified, explored or implemented as a result of such review process and any resulting litigation or dispute therewith, (iv) anticipated share purchases and (v) t he potential impact of the COVID - 19 pandemic on our business or the global economy as a whole are forward - looking statements. In addition, we, through our senior ma nagement, from time to time make forward - looking public statements concerning our expected future operations and performance and other developments. All of these forward - looking statements are subject to risks and uncertainties that may change at any time, including, with respect to our exploration of strategic alter nat ives, risks and uncertainties as to the terms, timing, structure, benefits and costs of any divestiture or separation transaction and whether one will be consummated at all, and the impact of any divestiture or separation transaction on our remaining businesses. Accordingly, our actual results may differ materially from those we expec ted . We derive most of our forward - looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe th at our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations are disclosed in ou r Annual Report on Form 10 - K filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 25, 2021, our Quarterly Reports on Form 10 - Q filed and to be fil ed with the SEC and other filings made with the SEC. These forward - looking statements speak only as of the time of this release and we do not undertake to publicl y update or revise them, whether as a result of new information, future events or otherwise, except as required by law. In addition, this presentation contains various operating data, including market share and market position, that are based on in ternal company data and management estimates. While management believes that our internal company research is reliable and the definitions of our markets which are used herein are appropriate, neither such research nor these definitions have been verified by an independent source and there are inherent challenges and limitat ion s involved in compiling data across various geographies and from various sources, including those discussed under “Industry and Market Data” in Laureate’s filing s w ith the SEC. Forward Looking Statements
3 © 2021 Laureate Education, Inc. In addition to the results provided in accordance with U.S. generally accepted accounting principles (GAAP) throughout this p res entation, Laureate provides the non - GAAP measurements of Adjusted EBITDA, Adjusted EBITDA margin, total debt, net of cash (or net debt), and Free Cash Flow. We h ave included these non - GAAP measurements because they are key measures used by our management and board of directors to understand and evaluate our core ope rating performance and trends, to prepare and approve our annual budget and to develop short - and long - term operational plans. Adjusted EBITDA consists of income (loss) from continuing operations, adjusted for the items included in the accompanying rec onc iliation. The exclusion of certain expenses in calculating Adjusted EBITDA can provide a useful measure for period - to - period comparisons of our core business. Addi tionally, Adjusted EBITDA is a key input into the formula used by the compensation committee of our board of directors and our Chief Executive Officer in connec tio n with the payment of incentive compensation to our executive officers and other members of our management team. Accordingly, we believe that Adjusted EBITDA an d Adjusted EBITDA margin, which is calculated by dividing Adjusted EBITDA by revenues, provide useful information to investors and others in understand ing and evaluating our operating results in the same manner as our management and board of directors. Total debt, net of cash (or net debt) consists of total gross debt, including seller notes, for Continuing Operations and Dis con tinued Operations, less total cash and cash equivalents for Continuing Operations and Discontinued Operations. Net debt provides a useful indicator about Laureate’s le verage and liquidity. Free Cash Flow consists of operating cash flow minus capital expenditures. Free Cash Flow provides a useful indicator about L aur eate’s ability to fund its operations and repay its debts. Laureate’s calculations of Adjusted EBITDA, Adjusted EBITDA margin, total debt, net of cash (or net debt), and Free Cash Flow ar e not necessarily comparable to calculations performed by other companies and reported as similarly titled measures. These non - GAAP measures should be considere d in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP results. Adjusted EBITDA is reconc ile d from the GAAP measure in the attached table “Non - GAAP Reconciliation.” We evaluate our results of operations on both an as reported and an organic constant currency basis. The organic constant cur ren cy presentation, which is a non - GAAP measure, excludes the impact of fluctuations in foreign currency exchange rates, acquisitions and divestitures, and othe r i tems. We believe that providing organic constant currency information provides valuable supplemental information regarding our results of operations, consist ent with how we evaluate our performance. We calculate organic constant currency amounts using the change from prior - period average foreign exchange rates to current - period average foreign exchange rates, as applied to local - currency operating results for the current period, and then exclude the impact of acquisitio ns and divestitures and other items described in the accompanying presentation. Presentation of Non - GAAP Measures
4 © 2021 Laureate Education, Inc. SUMMARY OVERVIEW Note: Throughout this presentation amounts may not sum to totals due to rounding Amounts presented for enrollments, Revenue, Adjusted EBITDA and Adjusted EBITDA margin are for continuing operations only
5 © 2021 Laureate Education, Inc. Continued Strong Execution Against all Operating & Strategic Priorities Executive Summary x Strong New Enrollment trends in Peru during its primary intake cycle; up 11% vs prior year period x Adjusted EBITDA ahead of expectations for Q1 driven by Peru intake and timing of expenses x Net Loss of $165M in Q1 driven by Laureate tradename impairment & discrete tax items x Reaffirming full - year 2021 guidance and 2022 outlook x Additional $1.95 billion of net proceeds from signed asset sales expected during 2021 1 x Announcing $200 million increase in share repurchases authorization (from $300 to $500 million) (1) Based on anticipated net proceeds (net of taxes, fees and other costs) for sales of Walden and Brazil. Includes assumed debt an d anticipated release of restricted cash (collateral for letter of credit and bonds at Walden); assumes all pending asset sale transaction close on announced ter ms.
6 © 2021 Laureate Education, Inc. Laureate Portfolio Overview Operations -- Remaining Operations -- Pending Asset Sales (as of March 31, 2021) Brazil Walden Mexico Peru Revenue 1 $1.1 billion Adjusted EBITDA 1 $280 million of Net Proceeds Expected 2 $1.95 billion (1) Based on 2022 outlook, see page #17. (2) Based on anticipated net proceeds (net of taxes, fees and other costs) for sales of Walden and Brazil. Includes assumed debt an d anticipated release of restricted cash (collateral for letter of credit and bonds at Walden); assumes all pending asset sale transaction close on announced terms. » 2 Universities » 35+ campuses » 180K+ students » 2 Universities / 1 Tech - Voc » 15+ campuses » 180K+ students
7 © 2021 Laureate Education, Inc. Mexico Peru Combined Population (M) 127M 33M 160M Higher Education Students (000s) 4,562 1,896 6,458 Higher Education Participation Rate 1 30% 47% 34% Market Share for Private Institution 2 44% 72% 56% Mexico & Peru Higher Education Market Overview Sources: UNESCO, World Bank, SEP database Attractive Markets with Significant Growth Opportunities Participation Rates Growing and Still Well Below Developed Markets (1) Defined as total enrollments as compared to 18 - 24 year old population (2) Private institution market share in higher education; for Mexico and Combined includes all states in which UVM or UNITEC have op erations (total private market share for all of Mexico is 35%); for Peru based on total country
8 © 2021 Laureate Education, Inc. Leading University Portfolio in Mexico & Peru Institution Market Segment QS Stars Overall University Rating Ratings/Ranking Mexico Universidad del Valle de México (UVM) Premium/ Traditional • Ranked #7 university in Mexico • One of only three 4 - Star rated universities in Mexico by QS Stars Mexico Universidad Tecnológica de México (UNITEC) Value/ Teaching • Largest private university in Mexico • 5 - Stars rated by QS Stars in categories of Teaching & Employability Peru Universidad Peruana de Ciencias Aplicadas (UPC) Premium/ Traditional • Ranked #3 university in Peru • Only 4 - Star rated university in Peru by QS Stars Peru Universidad Privada del Norte (UPN) Value/ Teaching • 2nd largest private university in Peru • 5 - Stars rated by QS Stars in categories of Teaching & Employability Peru CIBERTEC Tech/Voc N/A • 2nd largest private tech/ voc institute in Peru Sources: QS Stars , Guía Universitaria (UVM), Scimago Institutions Rankings (UPC) Operating Leading Brands in Multiple Attractive Market Segments
9 © 2021 Laureate Education, Inc. Q1 2021 PERFORMANCE RESULTS CONTINUING OPERATIONS ONLY (I.E. MEXICO, PERU AND CORPORATE SEGM ENTS)
10 © 2021 Laureate Education, Inc. Week Of 2/22 3/1 3/8 3/15 3/22 3/29 4/5 4/12 UPC UPN Cibertec COVID - Related Changes in Academic Calendar in Peru Impacting YoY Comparability Classes Started Late in 2020 Due to COVID -- Back to Normal Cycle Timing in 2021 2021 semester start date 2020 semester start date Delayed start in 2020 due to COVID Q1 Academic Calendar Timing Impacts - Peru • $18M in incremental Q1 revenue vs prior year period due to delayed class start in 2020 – Majority of benefit to reverse in Q2
11 © 2021 Laureate Education, Inc. 2021 First Quarter – Financial Summary Strong Primary Intake for Peru YoY Comparability Impacted by Academic Calendar Q1 ’21 Variance Vs. Q1 ‘20 Notes ($ in millions) (Enrollments in thousands) Results As Reported Organic/CC 1 New Enrollment 74K 59% 59% • +5% timing adjusted; strong primary intake for Peru Total Enrollment 366K 2% 2% • +2% timing adjusted Revenue $195 1% 5% • (5%) timing adjusted, Q1 is heavily weighted by Mexico (Peru is largely out of session) Adj. EBITDA $10 n.m. n.m. • Largely an out of session quarter (seasonally low period); $39M improvement YoY largely due to timing and strong Peru intake Adj. EBITDA margin 5.0% n.m. n.m. (1) Organic Constant Currency (CC) Operations excludes the period - over - period impact from currency fluctuations (if applicable), acq uisitions and divestitures, and other items. Other items include the impact of acquisition - related contingent liabilities for taxes other - than - income tax, net of chan ges in recorded indemnification assets. Note: Timing adjusted impacts noted are pro - forma for UPN - Peru semester start, which, in 2020, was moved to April 6 th due to COVID, and 1 - week earlier start of classes at Cibertec
12 © 2021 Laureate Education, Inc. SEGMENT RESULTS CONTINUING OPERATIONS ONLY (I.E. MEXICO, PERU AND CORPORATE SEGM ENTS)
13 © 2021 Laureate Education, Inc. (1) Organic Constant Currency (CC) Operations excludes the period - over - period impact from currency fluctuations (if applicable), acq uisitions and divestitures, and other items. Other items include the impact of acquisition - related contingent liabilities for taxes other - than - income tax, net of chan ges in recorded indemnification assets. Mexico Segment Results Q1 Results Notes ($ in millions) (Enrollments in thousands) Q1 ’21 Organic/CC Vs. Q1 ’20 (1) New Enrollment 27K (4%) • Lingering COVID impact • Small intake cycle, primary intake for Mexico will occur in September Total Enrollment 184K (5%) • Driven by COVID - related decline in 2020 intake results Revenue $135 (11%) • Impacted by lower enrollments from prior year intake & mix shift Adj. EBITDA $17 (1%) • Revenue softness largely offset by strong cost controls Adj. EBITDA margin 12.8% 196bps First Quarter Results Reflect Softer Enrollment Trends Due to COVID Mexico’s Primary Intake Will Occur in September
14 © 2021 Laureate Education, Inc. Peru Segment Results (1) Organic Constant Currency (CC) Operations excludes the period - over - period impact from currency fluctuations (if applicable), acq uisitions and divestitures, and other items. Other items include the impact of acquisition - related contingent liabilities for taxes other - than - income tax, net of chan ges in recorded indemnification assets. Q1 Results Notes ($ in millions) (Enrollments in thousands) Q1 ’21 Organic/CC Vs. Q1 ’20 (1) New Enrollment 47K 157% • +11% adjusted for timing; strong primary intake Total Enrollment 182K 11% • +10% adjusted for timing Revenue $57 68% • +19% adjusted for timing Adj. EBITDA $12 n.m. • Largely an out of session quarter, seasonally low period. $38M improvement YoY largely due to timing and strong intake Adj. EBITDA margin 20.2% n.m. Strong Primary Intake for Peru Driving Favorable Results Note: Timing adjusted impacts noted are pro - forma for UPN - Peru semester start, which, in 2020, was moved to April 6 th due to COVID, and 1 - week earlier start of classes at Cibertec
15 © 2021 Laureate Education, Inc. Q1 Debt Capitalization – Adjusted for Pending Asset Sales ($ in millions) Amount Comments (Net Debt) / Cash @ 3/31/21 ($286) See Appendix Net Proceeds – Pending Asset Sales 1 $1,950 Including assumed debt Adjusted Net Cash Position @ 3/31/21 $1,664 Post receipt of anticipated net cash proceeds & assumed debt Pro - Forma Net Cash Position of $1.6Bn Total of 196 Million Shares Outstanding (1) Based on anticipated net proceeds (net of taxes, fees and other costs) for sales of Walden and Brazil. Includes assumed debt an d anticipated release of restricted cash (collateral for letter of credit and bonds at Walden); assumes all pending asset sale transaction close on announced ter ms.
16 © 2021 Laureate Education, Inc. OUTLOOK
17 © 2021 Laureate Education, Inc. Laureate Summary Outlook – 2020 to 2022E (As Reported) 1 Reaffirming Full - Year 2021 Guidance and 2022 Outlook Total Enrollment (000s) Revenue ($M) Adjusted EBITDA ($M) 337 337 350 2020 2021E 2022E +4% $1,025 $1,020 $1,080 2020 2021E 2022E +6% $206 2020 2021E 2022E $185 $280 +51% Adjusted EBITDA Margin % 25.9 2021E 2020 2022E 20.1 18.1 780 bps Note: An outlook for 2021 & 2022 net income and reconciliation of the forward - looking 2021 & 2022 Adjusted EBITDA outlook to pro jected net income are not being provided as the company does not currently have sufficient data to accurately estimate the variables and individual adjustments for su ch outlook and reconciliation. Due to this uncertainty, the company cannot reconcile Adjusted EBITDA and its related margin to projected net income and its related marg in without unreasonable effort. (1) 2021 and 2022 guidance based on actual FX rates for January through April 2021, and current spot FX rates (local currency per US dollar) of MXN 19.97 & PEN 3.81 for May 2021 through December 2022. FX impact may change based on fluctuations in currency rates in future periods. 2021 is base d o n mid - point of guidance.
18 © 2021 Laureate Education, Inc. 2021 to 2022 Adjusted EBITDA Bridge (Guidance) 1 Strong Rebound Expected for 2022 ($USD in millions) $50 $13 $32 2021 Guidance $185 G&A Reduction FAS 5 / Indemnification Asset Operational Improvement 2022 Guidance $280 +51% (2) (1) Based on actual FX rates for January through April 2021, and current spot FX rates (local currency per US dollar) of MXN 19.9 7 & PEN 3.81 for May 2021 through December 2022. FX impact may change based on fluctuations in currency rates in future periods. (2) Based on mid - point of 2021 guidance. Note: An outlook for 2021 & 2022 net income and reconciliation of the forward - looking 2021 & 2022 Adjusted EBITDA outlook to pro jected net income are not being provided as the company does not currently have sufficient data to accurately estimate the variables and individual adjustments for su ch outlook and reconciliation. Due to this uncertainty, the company cannot reconcile Adjusted EBITDA and its related margin to projected net income and its related marg in without unreasonable effort.
19 © 2021 Laureate Education, Inc. Q2 2021 Guidance Details (1) Based on actual FX rates for April 2021, and current spot FX rates (local currency per US dollar) of MXN 19.97 & PEN 3.81 for Ma y through June 2021. FX impact may change based on fluctuations in currency rates in future periods. (USD millions ) Revenues Adj. EBITDA 2020 Q2 Results $304 $94 Organic Growth $1 – $21 ($9) – $1 Growth % 0% - 7% (9%) - 1% 2021 Q2 Guidance (Constant Currency) $305 – $325 $85 – $95 FX Impact (spot FX) (1) ($5) ($10) 2021 Q2 Guidance (@ spot FX) (1) $300 – $320 $75 – $85 Unfavorably impacted by timing of academic calendar; favorable offset was already captured in Q1 Note: An outlook for 2021 & 2022 net income and reconciliation of the forward - looking 2021 & 2022 Adjusted EBITDA outlook to pro jected net income are not being provided as the company does not currently have sufficient data to accurately estimate the variables and individual adjustments for su ch outlook and reconciliation. Due to this uncertainty, the company cannot reconcile Adjusted EBITDA and its related margin to projected net income and its related marg in without unreasonable effort.
20 © 2021 Laureate Education, Inc. APPENDIX
21 © 2021 Laureate Education, Inc. Q1 ’21 B / (W) Vs. Q1 ’20 Notes ($ in millions) Reported $ % Adjusted EBITDA 10 39 n.m. • Strong Peru intake and timing of academic calendar Depreciation & Amort. (23) (3) (16%) • Flat excluding amortization of tradename (moved to finite life asset in Q4 2020) Interest Expense, net (23) 2 8% Impairments (57) (53) n.m. • Impairment of Laureate tradename due to deemphasis of Laureate Network Other 41 (13) n.m. • Primarily gain on derivatives Income Tax (113) (343) n.m. • YoY variance largely due to discrete tax items in Q1 2020 Income/(Loss) From Continuing Operations (165) (371) n.m. Discontinued Operations (Net of Tax) 0 107 n.m. Net Income / (Loss) (165) (263) n.m. Income from Continuing Operations Impacted by Impairment of Laureate Tradename 2021 First Quarter – Net Income Reconciliation
22 © 2021 Laureate Education, Inc. Debt Capitalization At 3/31/21 ($ in millions) Continuing Operations Discontinued Operations Total Company Revolver $ - $ - $ - Sr. Notes $799 - $799 Local Debt / Seller Notes $203 $118 $320 Gross Debt $1,002 $118 $1,119 Cash ($561) ($272) ($833) Net Debt / (Cash) $440 ($154) $286 Net Debt of $286M as of March 31st
23 © 2021 Laureate Education, Inc. (1) Sale of both Walden University and Brazilian operations expected to close in 2021. (2) Other predominantly includes divestitures already closed and completed. (3) Organic Constant Currency (CC) Operations excludes the period - over - period impact from currency fluctuations (if applicable), acq uisitions and divestitures, and other items. Other items include the impact of acquisition - related contingent liabilities for taxes other - than - income tax, net of chan ges in recorded indemnification assets. Online 1 Brazil 1 Other 2 Total Disc. Ops ($ in millions) (Enrollments in thousands) Q1 ’21 Vs. Q1 ’20 Organic/ CC vs. Q1 ‘20 3 Q1 ’21 Vs. Q1 ’20 Organic/ CC vs. Q1 ‘20 3 Q1 ’21 Vs. Q1 ’20 Organic/ CC vs. Q1 ‘20 3 Q1 ’21 Vs. Q1 ’20 Organic/ CC vs. Q1 ‘20 3 New Enrollment 8 2% 2% 91 13% 13% 5 n.a. n.a. 104 n.a. n.a. Total Enrollment 58 3% 3% 283 5% 5% - n.a. n.a. 341 n.a. n.a. Revenue 157 1% 1% 69 (17%) (1%) 14 n.a. n.a. 240 n.a. n.a. Adjusted EBITDA 42 (4%) (4%) (1) 94% 75% 2 n.a. n.a. 42 n.a. n.a. Discontinued Operations – Q1 2021 vs. Q1 2020 Y - o - Y decline due to teach - out of the International Partnership business
24 © 2021 Laureate Education, Inc. Total Disc. Ops ($ in millions) Q1 ‘21 Q1 ‘20 (Loss) income from discontinued operations, net of tax $0 ($108) Income tax expense (benefit) $10 ($5) Other non - operating expense (income) $11 $55 Loss on sale of discontinued operations before taxes, net $17 $24 Operating income (loss) $37 ($34) Depreciation and amortization $0 $25 Share - based compensation expense 1 $0 $0 Loss on impairment of assets 2 $1 $0 EiP implementation expenses 3 $3 $8 Adjusted EBITDA (before allocations) $42 ($1) Allocations, net $0 ($2) Adjusted EBITDA $42 ($3) Discontinued Operations Q1 2021 vs. Q1 2020 – Adjusted EBITDA Reconciliation ( 1 ) Represents non - cash, share - based compensation expense pursuant to the provisions of ASC Topic 718. ( 2 ) Represents non - cash charges related to impairments of long - lived assets. ( 3 ) Excellence - in - Process (EiP) implementation expenses are related to our enterprise - wide initiative to optimize and standardize Laureate’s processes, creating vertical integration of procurement, information technology, finance, accounting and human resources . It included the establishment of regional shared services organizations (SSOs) around the world, as well as improvements to the Company's system of internal controls over financial reporting . The EiP initiative also includes other back - and mid - office areas, as well as certain student - facing activities, expenses associated with streamlining the organizational structure, an enterprise - wide program aimed at revenue growth, and certain non - recurring costs incurred in connection with the planned and completed dispositions .
25 © 2021 Laureate Education, Inc. • Large intake cycles at end of Q1 (Peru) and end of Q3 (Mexico) drive seasonality of earnings • Q2 and Q4 are typically Laureate’s strongest earnings quarters Revenue Seasonality Adjusted EBITDA Seasonality New Enrollments Seasonality Factors Affecting Seasonality Main intake cycles: – Q1 - Peru – Q3 - Mexico Academic calendar FX trends Intra - Year Seasonality Trends 18% 30% 24% 28% 17% 31% 23% 29% 19% 30% 24% 28% Q1 Q2 Q3 Q4 2018 2019 2020 - 24% 56% 8% 61% - 11% 47% 15% 49% - 14% 46% 24% 44% Q1 Q2 Q3 Q4 2018 2019 2020 39% 10% 50% 1% 39% 9% 51% 1% 28% 22% 48% 2% Q1 Q2 Q3 Q4 2018 2019 2020
26 © 2021 Laureate Education, Inc. Financial Results & Tables
27 © 2021 Laureate Education, Inc. Financial Tables Note: Dollars in millions, except per share amounts, and may not sum to total due to rounding Consolidated Statements of Operations For the three months ended March 31, IN MILLIONS 2021 2020 Change Revenues $ 194.7 $ 192.3 $ 2.4 Costs and expenses: Direct costs 181.8 220.6 (38.8 ) General and administrative expenses 42.6 45.1 (2.5 ) Loss on impairment of assets 56.7 3.8 52.9 Operating loss (86.4 ) (77.1 ) (9.3 ) Interest income 0.7 0.6 0.1 Interest expense (23.5 ) (25.3 ) 1.8 Gain on derivatives 29.3 0.8 28.5 Other expense, net — (0.1 ) 0.1 Foreign currency exchange gain, net 28.2 78.7 (50.5 ) Loss on disposal of subsidiaries, net — (1.8 ) 1.8 Loss from continuing operations before income taxes and equity in net income of affiliates (51.7 ) (24.1 ) (27.6 ) Income tax (expense) benefit (112.9 ) 230.0 (342.9 ) Equity in net income of affiliates, net of tax — 0.2 (0.2 ) (Loss) income from continuing operations (164.5 ) 206.1 (370.6 ) Loss from discontinued operations, net of tax (0.4 ) (107.8 ) 107.4 Net (loss) income (164.9 ) 98.3 (263.2 ) Net loss attributable to noncontrolling interests — 1.3 (1.3 ) Net (loss) income attributable to Laureate Education, Inc. $ (164.9 ) $ 99.6 $ (264.5 ) Net (loss) income available to common stockholders $ (164.9 ) $ 99.6 $ (264.5 ) Basic and diluted earnings (loss) per share: Basic weighted average shares outstanding 200.2 209.8 (9.6 ) Diluted weighted average shares outstanding 200.2 210.2 (10.0 ) Basic and diluted (loss) earnings per share $ (0.82 ) $ 0.47 $ (1.29 )
28 © 2021 Laureate Education, Inc. Financial Tables Note: Dollars in millions, and may not sum to total due to rounding Revenue and Adjusted EBITDA by segmen t IN MILLIONS % Change $ Variance Components For the three months ended March 31, 202 1 20 20 Reported Organic Constant Currency (2) Total Organic Constant Currency Other Acq/Div. FX Revenues Mexico $ 135.4 $ 154.2 (12)% (11)% $ (18.8 ) $ (16.2 ) $ — $ — $ (2.6 ) Peru 57.5 36.5 58% 68% 21.0 25.0 — — (4.0 ) Corporate & Eliminations 1.8 1.6 13% 13% 0.2 0.2 — — — Total Revenues $ 194.7 $ 192.3 1% 5% $ 2.4 $ 9.0 $ — $ — $ (6.6 ) Adjusted EBITDA Mexico $ 17.3 $ 23.3 (26)% (1)% $ (6.0 ) $ (0.3 ) $ (6.8 ) $ — $ 1.1 Peru 11.6 (26.7 ) 143% 146% 38.3 39.0 — — (0.7 ) Corporate & Eliminations (19.2 ) (26.0 ) 26% 26% 6.8 6.8 — — — Total Adjusted EBITDA $ 9.7 $ (29.4 ) 133% 155% $ 39.1 $ 45.5 $ (6.8 ) $ — $ 0.4 ( 2 ) Organic Constant Currency results exclude the period - over - period impact from currency fluctuations, acquisitions and divestitures, and other items . Other items include the impact of acquisition - related contingent liabilities for taxes other - than - income tax, net of changes in recorded indemnification assets . Organic Constant Currency is calculated using the change from prior - period average foreign exchange rates to current - period average foreign exchange rates, as applied to local - currency operating results for the current period . The “Organic Constant Currency” % changes are calculated by dividing the Organic Constant Currency amounts by the 2020 Revenues and Adjusted EBITDA amounts, excluding the impact of the divestitures .
29 © 2021 Laureate Education, Inc. Financial Tables Consolidated Balance Sheets Note: Dollars in millions, and may not sum to total due to rounding IN MILLIONS March 31, 2021 December 31, 2020 Change Assets Cash and cash equivalents $ 561.3 $ 750.1 $ (188.8 ) Receivables (current), net 115.1 111.9 3.2 Other current assets 167.0 146.8 20.2 Current assets held for sale 467.8 435.0 32.8 Property and equipment, net 543.0 578.5 (35.5 ) Operating lease right - of - use assets, net 428.2 462.8 (34.6 ) Goodwill and other intangible assets 715.8 800.4 (84.6 ) Deferred income taxes 90.6 130.6 (40.0 ) Other long - term assets 56.9 72.4 (15.5 ) Long - term assets held for sale 1,338.3 1,482.5 (144.2 ) Total assets $ 4,484.0 $ 4,970.9 $ (486.9 ) Liabilities and stockholders' equity Accounts payable and accrued expenses $ 178.7 $ 200.9 $ (22.2 ) Deferred revenue and student deposits 85.9 47.2 38.7 Total operating leases, including current portion 476.0 519.1 (43.1 ) Total long - term debt, including current portion 951.0 995.7 (44.7 ) Other liabilities 283.5 240.0 43.5 Current and long - term liabilities held for sale 613.7 702.3 (88.6 ) Total liabilities 2,588.8 2,705.2 (116.4 ) Redeemable noncontrolling interests and equity 1.7 1.7 — Total stockholders' equity 1,893.5 2,263.9 (370.4 ) Total liabilities and stockholders' equity $ 4,484.0 $ 4,970.9 $ (486.9 )
30 © 2021 Laureate Education, Inc. Financial Tables Consolidated Statements of Cash Flows Note: Dollars in millions, and may not sum to total due to rounding For the three months ended March 31, IN MILLIONS 2021 2020 Change Cash flows from operating activities Net (loss) income $ (164.9 ) $ 98.3 $ (263.2 ) Depreciation and amortization 22.7 44.2 (21.5 ) Loss on impairment of assets 57.7 3.8 53.9 Loss on sales and disposal of subsidiaries and property and equipment, net 16.5 21.2 (4.7 ) Gain on derivative instruments (29.3 ) (0.8 ) (28.5 ) Deferred income taxes 84.4 (248.7 ) 333.1 Unrealized foreign currency exchange gain (23.7 ) (29.7 ) 6.0 Income tax receivable/payable, net (16.7 ) 2.7 (19.4 ) Working capital, excluding tax accounts 25.6 41.8 (16.2 ) Other non - cash adjustments 39.1 63.7 (24.6 ) Net cash provided by (used in) operating activities 11.3 (3.5 ) 14.8 Cash flows from investing activities Purchase of property and equipment (11.7 ) (24.6 ) 12.9 Expenditures for deferred costs (1.9 ) (3.5 ) 1.6 Receipts from sales of discontinued operations, net of cash sold, and property and equipment 30.8 4.0 26.8 Payments on derivatives related to sale of discontinued operations (18.3 ) — (18.3 ) Investing other, net — 0.1 (0.1 ) Net cash used in investing activities (1.1 ) (24.0 ) 22.9 Cash flows from financing activities (Decrease) increase in long - term debt, net (52.7 ) 273.0 (325.7 ) Payments of deferred purchase price for acquisitions — (1.5 ) 1.5 Proceeds from exercise of stock options — 26.8 (26.8 ) Payments to repurchase common stock (145.2 ) (29.2 ) (116.0 ) Financing other, net (1.2 ) (1.1 ) (0.1 ) Net cash (used in) provided by financing activities (199.2 ) 267.9 (467.1 ) Effects of exchange rate changes on Cash and cash equivalents and Restricted cash (6.9 ) (7.7 ) 0.8 Change in cash included in current assets held for sale (3.5 ) 10.1 (13.6 ) Net change in Cash and cash equivalents and Restricted cash (199.3 ) 242.8 (442.1 ) Cash and cash equivalents and Restricted cash at beginning of period 867.3 97.8 769.5 Cash and cash equivalents and Restricted cash at end of period $ 668.0 $ 340.6 $ 327.4
31 © 2021 Laureate Education, Inc. Financial Tables Non - GAAP Reconciliation (1 of 2) Note: Dollars in millions, and may not sum to total due to rounding The following table reconciles (Loss) income from continuing operations to Adjusted EBITDA and Adjusted EBITDA margin : For the three months ended March 31, IN MILLIONS 2021 2020 Change (Loss) income from continuing operations $ (164.5 ) $ 206.1 $ (370.6 ) Plus: Equity in net income of affiliates, net of tax — (0.2 ) 0.2 Income tax expense (benefit) 112.9 (230.0 ) 342.9 Loss from continuing operations before income taxes and equity in net income of affiliates (51.7 ) (24.1 ) (27.6 ) Plus: Loss on disposal of subsidiaries , net — 1.8 (1.8 ) Foreign currency exchange gain, net (28.2 ) (78.7 ) 50.5 Other expense, net — 0.1 (0.1 ) Gain on derivatives (29.3 ) (0.8 ) (28.5 ) Interest expense 23.5 25.3 (1.8 ) Interest income (0.7 ) (0.6 ) (0.1 ) Operating loss (86.4 ) (77.1 ) (9.3 ) Plus: Depreciation and amortization 22.8 19.7 3.1 EBITDA (63.6 ) (57.4 ) (6.2 ) Plus: Share - based compensation expense (3) 1.3 1.5 (0.2 ) Loss on impairment of assets (4) 56.7 3.8 52.9 EiP implementation expenses (5) 15.3 22.8 (7.5 ) Adjusted EBITDA $ 9.7 $ (29.4 ) $ 39.1 Revenues $ 194.7 $ 192.3 $ 2.4 (Loss) income from continuing operations margin (84.5 )% 107.2 % - 19,166 bps Adjusted EBITDA margin 5.0 % (15.3 )% 2,027 bps (3) Represents non - cash, share - based compensation expense pursuant to the provisions of ASC Topic 718. (4) Represents non - cash charges related to impairments of long - lived assets. ( 5 ) Excellence - in - Process (EiP) implementation expenses are related to our enterprise - wide initiative to optimize and standardize Laureate’s processes, creating vertical integration of procurement, information technology, finance, accounting and human resources . It included the establishment of regional shared services organizations (SSOs) around the world, as well as improvements to the Company's system of internal controls over financial reporting . The EiP initiative also includes other back - and mid - office areas, as well as certain student - facing activities, expenses associated with streamlining the organizational structure, an enterprise - wide program aimed at revenue growth, and certain non - recurring costs incurred in connection with the planned and completed dispositions .
32 © 2021 Laureate Education, Inc. Financial Tables Non - GAAP Reconciliation (2 of 2) Note: Dollars in millions, and may not sum to total due to rounding The following table reconciles operating cash flow to Free Cash Flow for the three months ended March 31 , 2021 and 2020 : IN MILLIONS 2021 2020 Change Net cash provided by (used in) operating activities $ 11.3 $ (3.5 ) $ 14.8 Capital expenditures: Purchase of property and equipment (11.7 ) (24.6 ) 12.9 Expenditures for deferred costs (1.9 ) (3.5 ) 1.6 Free Cash Flow $ (2.3 ) $ (31.6 ) $ 29.3
33 © 2021 Laureate Education, Inc.
C;5M5